dacarbazine has been researched along with Viremia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knox, B; Mai, H; Mirza, K; Singh, D | 1 |
| Huh, J; Kim, S; Lee, SW; Park, CS; Park, JH; Park, JS; Suh, C; Sung, H; Yoon, DH | 1 |
2 other study(ies) available for dacarbazine and Viremia
| Article | Year |
|---|---|
Hodgkin's lymphoma with HLH and complete remission with brentuximab-based therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Epstein-Barr Virus Infections; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Remission Induction; Vinblastine; Viremia | 2019 |
Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Biomarkers; Bleomycin; Dacarbazine; Disease-Free Survival; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Middle Aged; Prognosis; Real-Time Polymerase Chain Reaction; Reed-Sternberg Cells; Republic of Korea; RNA, Viral; Tumor Virus Infections; Vinblastine; Viremia; Young Adult | 2016 |